CML-046 Dose Modification Dynamics of Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia From the PACE and OPTIC Trials

Autor:	Apperley, Jane 1, Kantarjian, Hagop 2, Deininger, Michael 3, Abruzzese, Elisabetta 4, Cortes, Jorge 5, Chuah, Charles 6, DeAngelo, Daniel J. 7, DiPersio, John 8, Hochhaus, Andreas 9, Lipton, Jeffrey H. 10, Nicolini, Frank 11, Pinilla-Ibarz, Javier 12, Rea, Delphine 13, Rosti, Gianantonio 14, Rousselot, Philippe 15, Mauro, Michael 16, Shah, Neil 17, Talpaz, Moshe 18, Vorog, Alexander 19, Ren, Xiaowei 19, Jabbour, Elias 2
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S284-S285
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect